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Preface 
 
In the summer of 2012 and 2013, I got to be a part of a PhD project on the characterization of 
the yeast fungus Candida glabrata. The project focused on genetic characterization, using a 
method called multilocus sequence typing (MLST) to detect variations in the genome of 
different C. glabrata strains. C. glabrata was until recently considered a commensal in 
humans, one of the many harmless microorganisms that inhabit the human body. However, 
with the increasing number of patients with reduced host response in medicine, C. glabrata is 
becoming an increasingly important human pathogen. 
 
In the PhD project, we examined over 250 strains of C. glabrata, all sampled from human 
sources, mainly from systemic infections. While this is not strictly the dentist’s area of 
expertise, it is still possible to draw parallels to oral yeast infections, also known as oral 
candidiasis. Dentists and dental hygienists may not know of C. glabrata, but will know a 
different yeast, more common in the oral cavity, namely Candida albicans. C. albicans is 
prevalent in both systemic and oral infections.  
 
While our work with C. glabrata was very interesting, it was not my intention to use it in my 
master thesis. The idea came later, as I saw that connections could be drawn between systemic 
infections and oral candidiasis, and C. glabrata and C. albicans. I decided to write a two-part 
thesis. Part 1 is a literary review of oral candidiasis, where I focus on clinically relevant 
information, such as diagnosis and treatment of the disease. Part 2 is a discussion of C. 
glabrata, and molecular methods used in the PhD project. Lastly, I got to work with a small 
selection of C. glabrata strains, specifically for this thesis, and I present my results at the end 
of part 2.  
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Part 1: Oral candidiasis 
 
Introduction 
The oral cavity is home to many different microorganisms, including bacteria, viruses, fungi, 
and sometimes protozoa (1). The different tissues and fluids in the oral cavity, as well as the 
range of foods that pass through, provide a unique environment that allows various 
microorganisms to thrive (1). Sometimes the organisms live in complete harmony with their 
host, other times they can cause harm in the form of dental caries, periodontitis, and other 
infections. The shift from harmless to harmful was described by P.D. Marsh (2) in the 
ecological plaque hypothesis.  
 
Candida species
1
, commonly Candida albicans (3, 4), can be present in the mouth of healthy 
individuals without causing disease to its host (3-5). Like bacteria, fungi can be part of the 
natural oral microflora
2
, and like with bacteria, a shift in the balanced microflora can lead to 
infection and disease. Oral candidiasis is one term used to describe such an infection, and 
other names are oral candidosis, oral thrush (specifically pseudomembranous candidiasis, see 
below), and candidal stomatitis. It is also referred to as a biofilm disease (6).  
 
Candidiasis is defined as an infection caused by a fungi of the genus Candida, and the term 
oral candidiasis is only used when describing a clinically visible lesion in the oral cavity (4). 
The lesion can vary in size, shape and colour, largely dependant on the predisposing factors 
behind the disease (4). The patient’s complaints can vary from none, to extremely painful and 
completely disabling (7).  With this wide array of clinical presentations, it is important for the 
dental practitioner to have the knowledge for diagnosis and treatment of oral candidiasis.  
 
Pathogenesis and predisposing factors 
The formation of an oral candidiasis lesion is usually caused by the establishment of a 
complex biofilm
3
 containing C. albicans as well as other microorganisms (4). The biofilm 
adheres to oral surfaces, such as teeth, mucosa and dentures, and triggers an immune response 
heavy in neutrophils (4). The biofilm is the perfect environment for the fungal cells to thrive, 
                                                          
1
 Genus of yeast that exists in humans, both harmless and a cause of infection.  
2
 The collection of microorganisms living in the oral cavity, of any given individual at any given time. 
3
 Organized group of microorganisms that adhere to each other and any surface, particularly teeth and dentures 
in the mouth.  
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as the neutrophils cannot reach outside the body’s own borders (4). C. albicans pathogenicity4 
is linked to it phenotypic switching, between the commensal yeast form, and the invasive 
hyphal form (8). Hyphae are elongations of the fungal cells, a tube without constrictions that 
can aid the pathogen in invading its host (8). C. albicans can invade the superficial layers of 
the oral epithelium, and cause proteolytic breakdown of E-cadherin (4). E-cadherin is an 
important structural protein in the oral cavity, responsible for keeping the epithelium 
continuous, and a barrier against harmful substances (9). When E-cadherin is broken down, 
the tissue weakens and the protective barrier is compromised (9).  C. albicans uses this to 
migrate deeper into the tissue (9). Less is known about the pathogenicity of Candida glabrata, 
which will be discussed further in part 2.  
 
Hyposalivation 
Saliva has antibacterial and antifungal properties that help protect the healthy patient from 
infection. Proteins such as secretory IgA, lysozyme, mucin and lactoferrin have inhibitory 
effects on Candida that stop adhesion and multiplication on the mucosal surface (10). When a 
patient suffers from hyposalivation, and the quantity or quality of saliva is affected, the risk of 
infection increases (10, 11). Causes of hyposalivation include taking medicine, especially 
polypharmacy
5
, cancer treatment, nutritional deficiency, and Sjögren’s syndrome6 (3, 6, 10, 
11). 
 
Biofilm 
With good oral hygiene, the biofilm is constantly being disturbed. Though oral hygiene alone 
will not prevent dental caries and periodontitis, it is an important prerequisite for reducing the 
prevalence of disease.  When the biofilm is left alone for some time, it becomes a highly 
structured, highly protected, community of microorganisms, which is capable of doing harm, 
also in the form of oral candidiasis (6). The candidal hyphae and extrapolymeric material 
increases biofilm growth and structural integrity (6). The non-shedding surfaces of the oral 
cavity comprise the teeth, and the surface increases with the addiction of restorations, 
orthodontic appliances, and removable dentures (6). When the patient is unable or unwilling 
to maintain proper oral hygiene, the risk of oral candidiasis will increase (6). 
 
                                                          
4
 An organism’s ability to cause disease.  
5
 Regular use of many different drugs, causing their adverse effects to pile up.  
6
 Chronic, autoimmune disease that causes destruction of the salivary glands.  
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Antibiotics 
The use of broad-spectrum antibiotics alters the oral microflora (5). Destruction of the normal 
bacterial population favours yeast growth, as it decreases the competition for nutrition and 
cell adhesion (5). Therefore the use of broad-spectrum antibiotics is a well known 
predisposing factor for oral candidiasis (5, 6). 
 
General predisposing factors 
A functioning immune system is essential to fight all threats of infection. Topical corticoids, 
such as steroid inhalers for treating asthma, can give characteristic circumscribed lesions that 
will be discussed later. Systemic immunosuppressive medication, used to treat autoimmune, 
inflammatory, and neoplastic disorders, will increase susceptibility to infection (5). For this 
reason, hospitalized cancer patients are especially at risk for developing severe oral 
candidiasis, as well as dangerous invasive candidiasis (12). HIV-infected patients and patients 
with diagnosed AIDS are at risk for the same reason (5). Other high-risk groups are discussed 
below.  
 
Prevalence and high-risk groups 
Reports have shown that 20-75 % of the general population are carriers of one or more 
species of Candida, without showing any symptoms of infection (13). C. albicans is 
considered a commensal
7
 in healthy individuals, so it will often exist in the oral cavity 
without any corresponding candidiasis. C. albicans is the most frequent cause of oral 
candidiasis (70-80 % (3, 11, 14)). Isolating C. albicans from the oral cavity has shown a 
higher incidence in immunocompromised
8
 patients than in healthy individuals (see table 1). 
 
                                                          
7
 Organism living in a host without causing harm to it. 
8
 Having an immune system that is somehow impaired or damaged. 
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Population group Incidence of C. albicans in the oral cavity (%) 
 Lynch 
(1994) 
(15) 
Cannon et 
al. (1999) 
(16) 
Akpan et 
al. (2002) 
(13) 
Grimoud 
et al. 
(2003) 
(17) 
Samarana
yake et al. 
(2009) (7) 
Giannini, 
et al. 
(2011) 
(11) 
Healthy adults 20 18 30-45 - - - 
Healthy children 9 - 45-65 - - - 
Neonates, infants 16 13 45 - - - 
People who wear 
removable 
dentures 
60 - 50-65 - - - 
Patients in 
hospitals or care 
facilities  
- 41 65-88 67 - - 
Patients with 
leukaemia, 
undergoing 
chemotherapy 
- - 90 - - - 
Patients with 
HIV 
- - 95 - 84-100 90 
Table 1: Incidence of C. albicans in the oral cavity of different population groups. The numbers are pulled 
from different review articles, from 1994 to 2011. The early studies have listed the incidence in healthy 
population groups, while the later studies focus on patients with HIV. With the growing amount of 
immunocompromised patients, widespread use of antibiotics and chemotherapy, as well as increased life 
expectancy of HIV-infected individuals, the incidence of opportunistic fungal infections also increase, but in 
different population groups than were previously examined and with several other species than C. albicans 
involved (7).  
 
Though C. albicans is the most common cause of yeast infections, the non-albicans Candida 
species
9
 are increasing in prevalence. C. glabrata is the second most common species in 
candidiasis or candidemia
10
, and the number one non-albicans Candida spp. in blood stream 
infections (18). In patients younger than 13 years, Candida parapsilosis is almost as common 
as C. albicans, causing 34 % of all candidemias (18). C. glabrata is less common in infants 
and children (19). Unlike most Candida spp., C. glabrata does not produce hyphal structures. 
C. glabrata is common in blood stream infections, and resistance to azole antifungals
11
 is 
common (6). C. glabrata was not seen as an important oral pathogen, but due to its 
opportunistic nature, and resistance to azoles, it is becoming increasingly involved in oral 
candidiasis, especially in HIV and cancer patients (20). Candida tropicalis is important in 
                                                          
9
 Candida species other than C. albicans. 
10
 A type of fungemia, or blood infection. 
11
 Group of commonly used antifungal agents.  
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patients with neutropenia
12
 and leukaemia, and is potentially very aggressive (18, 19). 
Candida krusei is also associated with haematological malignancies and neutropenia (19). 
Azole resistance is common in C. krusei, which is a concern, especially to high-risk patients 
(6). 
 
Classification 
Oral candidiasis can be divided into many different types, often by its clinical appearance in 
the mouth, and sometimes by its predisposing factors. The following are the most commonly 
described types of oral candidiasis.  
 
Pseudomembranous candidiasis  
Pseudomembranous candidiasis, or oral thrush, is the most commonly diagnosed and most 
easily recognizable form of oral candidiasis (11). In this type of infection, the mucosa is 
covered in a white or yellow pseudomembrane, consisting of fibrin, desquamated epithelial 
cells, inflammatory cells, and sometimes bacteria or food debris (3, 13). The plaque is also 
heavily infiltrated by fungal hyphae (13, 21). With some pressure, the membrane can be 
removed, and underneath the mucosa is erythematous and inflamed (4, 11, 14, 15). If removal 
of the membrane reveals bleeding mucosa, the patient is most likely suffering from additional 
conditions such as erosive lichen planus or pemphigus, which are often associated with oral 
candidosis in the affected areas (7).   
 
The infection can often be asymptomatic, and other times the patient will describe discomfort, 
burning, tenderness or changes in taste when large parts of the mucosa are involved (4, 7). 
Most commonly affected is the buccal mucosa, tongue, soft palate and oropharynx (3, 4, 11, 
13).  
                                                          
12
 Immune disorder affecting the production of neutrophil granulocytes, causing an abnormally low number of 
these cells. 
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 Pseudomembranous candidiasis  
From Farah et al. 2010 (5) 
 
 
Acute pseudomembranous candidiasis 
From Akpan et al. 2002 (13) 
 
Erythematous candidiasis 
Erythematous candidiasis is probably the most common form of oral candidiasis. Due to its 
less pathognomonic appearance
13
, however, it is not as easily diagnosed as its 
pseudomembranous counterpart (7). Erythematous candidiasis appears as a red, more or less 
circumscribed lesion in the hard palate or dorsum linguae (3, 4). It can persist chronically and 
is usually asymptomatic (3, 4). A burning or itching sensation can occur (11). Some 
distinguish between symptomatic and asymptomatic erythematous candidiasis (5, 14). A 
bright red tongue can occur, and the differential diagnosis in these cases is low serum B12, 
folate and iron (14).  
 
Denture stomatitis, or chronic atrophic candidiasis (11, 22), is a type of erythematous 
candidiasis. It appears as lesions in the palate, and is caused by removable dentures, when the 
wearer does not remove it at night or fails to clean it properly (3, 4). An ill-fitted denture is 
also a contributing factor, as repeated trauma against the mucosa can cause an increase in 
penetration of Candida-antigens and –toxins (1). The lesion is restricted to the mucosa 
covered by the denture, and is typically asymptomatic (14, 15).  
 
When erythematous candidiasis affects the tongue, a smooth red patch appears where the 
filiform papillae atrophy. If this patch is round or oval, and is located in the middle of the 
tongue, it is called median rhomboid glossitis (3, 4, 7), or central papillary atrophy (14). This 
                                                          
13
 Typical or characteristic for a certain disease. 
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type of lesion may be caused by bacteria as well as Candida and other fungi, so the etiology is 
not completely clear (7). Predisposing factors for this particular type of lesion is smoking and 
the use of steroid inhalers (14). 
 
 
Erythematous candidiasis in a patient 
wearing a removable prosthesis 
From Giannini et al. 2011 (11) 
 
 
Median rhomboid glossitis 
From Farah et al. 2010 (5) 
 
Linear gingival erythema 
Linear gingival erythema is a specific type of oral fungal infection that most frequently affects 
patients with HIV (7, 11). The lesion is a red band stretching along the gingival margin, and 
can be mistaken for gingivitis (7). Though the diagnostic criteria are not entirely clear, linear 
gingival erythema is defined as “a nonplaque-induced gingivitis presenting 
a distinct erythematous band of at least 2 mm along the margin of gingivae, with either 
diffuse or punctuate erythema of the attached gingivae” (7). Improved oral hygiene, even 
with regular professional cleaning, is not an efficient treatment (7, 11). The fungus 
Saccharomyces cerevisiae, Candida dubliniensis, and opportunistic bacteria are thought to be 
the pathogens associated with this type of lesion (7).  
 
10 
 
 
Linear gingival erythema 
From Samaranayake et al. 2009 (7) 
 
Hyperplastic candidiasis 
Hyperplastic candidiasis is the least common form of oral candidiasis, but its malignant 
potential
14
 makes it an important one (11, 13, 14). It is also called candidal leukoplakia, and 
like ordinary leukoplakia
15
, it appears as white lesions that cannot be rubbed off (3, 7, 14). Its 
appearance varies greatly, from small, translucent, slightly raised lesions, to large, plaque-like 
areas that feel hard and rough on palpation (7). It is most commonly found on the buccal 
mucosa and is associated with smoking (13, 15). Though it cannot be rubbed off, it can be 
separated from leukoplakia by microbiological tests, attempting treatment with anti-fungal 
medicine, or by taking a biopsy for histological examination (7). The fungi’s hyphae often 
invade the oral epithelium, which is hyperplastic (13). As previously mentioned, the lesions of 
hyperplastic candidiasis can sometimes turn malignant, but there is controversy regarding the 
importance of Candida spp. as a contributing risk factor (11, 13). 
 
                                                          
14
 Potential for developing into a cancerous lesion. 
15
 A white mucosal lesion that can not be diagnosed as anything else.  
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Hyperplastic candidiasis in an 
immunosuppressed patient 
From Muzyka 2005 (22) 
 
Chronic hyperplastic candidiasis 
From Akpan et al. 2002 (13) 
 
 
Angular cheilitis  
Angular cheilitis is a multifactorial condition that can be caused by bacteria, especially 
Staphylococcus aureus
16
 (3, 7, 11), fungi, or a combination of both. It is also affected by the 
loss of vertical dimension
17
, vitamin B12 deficiency and iron deficiency anaemia (7, 13-15). 
The connection between folic-acid deficiency and angular cheilitis was made in 1971 by J.A. 
Rose (23), who found a significantly higher occurrence of folic-acid deficiency in patients 
with angular cheilitis. Folic-acid therapy was also found to heal the lesions, though this 
occurred in only two of the patients, and thus was not conclusive (23).  
 
Angular cheilitis affects the corners of the mouth and the surrounding skin and mucosa. Folds 
in the skin create a constantly moist environment, with perfect growth conditions for both 
bacteria and fungi (3, 13, 14). The result is a red, sensitive lesion, with fragile skin that can 
rupture when stretched, such as when opening the mouth wide during dental treatment (4, 11). 
Treatment of the fungal infection will often cure the lesion, but if the vertical dimension is not 
improved (denture relining, see below), or the nutrient deficiencies are not treated, the lesions 
will most likely reoccur (15). 
 
                                                          
16
 Bacteria commonly involved in skin and lung infections.  
17
 Facial height, affected by the size of the alveolar ridges and the presence of teeth.  
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Angular cheilitis in an  
elderly denture wearer 
From Samaranayake et al. 2009 (7) 
 
Angular cheilitis  
From Akpan et al. 2002 (13) 
 
Diagnostic tests 
Diagnosis of oral candidiasis relies largely on recognition of its physical appearance. 
However, tests should be made to confirm the diagnosis and determine susceptibility to 
antifungals. This can be done using a microscope to see the fungal cells in a sample, or 
macroscopically with a fungal culture (3, 4). 
 
Smear staining 
For a microscopic test, a smear of the lesion is made. The smear can be stained in a number of 
different ways, and fixed to glass microscope slide with alcohol, or by simply air drying, 
before viewing under a microscope (3-5). Periodic acid-Schiff staining (PAS) can confirm the 
presence of hyphae in the case of pseudomembranous candidiasis, but usually not with other 
types (5). A potassium hydroxide (KOH) solution can also be used, with gentle heating, which 
causes the epithelial cells from the mucosa to dissolve, leaving a clearer view of the fungal 
cells (3, 4). Care should be taken when making a microbiological sample. The sampled area 
should be representative for the actual infection, but this might be difficult as the mouth looks 
quite different when open and closed. Areas that appear distant might actually be in constant 
contact when the patient closes their mouth (6). While the mucosa should be swabbed, an 
adjacent non-renewing surface will often carry a lot of extra organisms (6). A moistened 
wooden tongue blade can be used with good results (11). 
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Biopsy 
In cases of hyperplastic candidiasis, or rather, in cases where it is suspected, a biopsy should 
be made along with the smear stain (3, 4). The mucosal tissue sample is placed in 10% 
formalin, before further processing, embedding in paraffin, and cutting (11). A thin section is 
placed on a glass microscope slide and stained (for example PAS), and can be examined 
under a microscope (11). In the case of a superficial fungal infection, the fungi can be found 
in the parakeratin layer, the outmost layer for the epithelium (11). 
 
 
C. albicans within the parakeratin layer (PAS stain, hyphae are magenta in colour) 
From Giannini et al. 2011 (11) 
 
Fungal cultures 
Fungal cultures can be cultured on Sabouraud dextrose agar (SDA) representing a common 
selective fungal growth medium (3-5). White colonies appear and indicate a positive culture 
result, but it does not necessarily indicate infection (11). The cultures can be analyzed further 
for identification of the species and/or for testing of antifungal susceptibility (5). To 
determine sensitivity, or resistance, to an antifungal medication, fungal cultures with an 
Epsilometer test, or E-test, can be used (24). An agar with chromogenic substrate (chromagar) 
can be used with mixed-species samples, as the different species and their enzymes will react 
differently, their colonies will have various colours (3). For further identification of species, a 
method called matrix assisted laser desorption ionization time-of-flight, or MALDI-TOF, can 
be used. Quick diagnostic methods are increasingly important, and the MALDI-TOF method 
has gradually become both reliable and fast when used for diagnostic purposes. The method 
analyses proteins and other large molecules, and has been found to effectively discriminate 
between species of fungi (25). 
14 
 
 
 
Chromagar showing different Candida spp.
18
 
1=C. glabrata; 2=C. albicans; 3=C. krusei; 4=C. tropicalis. 
 
Differential diagnosis 
As described above, hyperplastic candidiasis has the same appearance as leukoplakia, which 
has the potential to turn cancerous (26). A number of white and red lesions in the oral mucosa 
can have other causes than oral candidiasis (6). A common cold, or an allergy to oral care 
products can cause erythema, sore mouth, and nonspecific inflammation which appears 
similar to oral candidiasis (6). Mucocutaneus disease, such as oral lichen planus (5, 6), 
lichenoid reactions, discoid lupus erythematosus, erythema multiforme, pernicious anaemia, 
and epithelial dysplasia (5), can clinically resemble erythematous candidiasis. Oral lichen 
planus lesions can in addition be infected by Candida, and a study by Kragelund et al. found 
that non-albicans Candida were overrepresented in these cases (27). Gingivitis, periodontitis, 
and angular cheilitis can be caused by bacteria, Candida, or a combination of both. Several 
medications, such as methotrexate
19
, can also cause redness in the oral mucosa (6). Chemical 
burns, traumatic lesions, and syphilis can cause a pseudomembrane similar to the one of 
pseudomembranous candidiasis (5).  
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 Photo from Leading International Fungal Education,  http://www.life-worldwide.org/ 
19
 Cytostatic drug.  
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Treatment of oral candidiasis 
Identifying the cause of infection for each individual patient is the first step in treating oral 
candidiasis. Correcting the risks can be simple or challenging, depending on their severity. In 
many cases it becomes necessary to involve the patient’s physician, if the underlying 
condition is not so severe that they are involved from the start. The dentist’s role can vary 
from curing the infection completely, to providing palliative care of the oral conditions. 
 
Oral hygiene 
In cases such as denture stomatitis, instructing the patient in proper oral hygiene is important 
(6, 13). If the patient is incapable of managing their own oral hygiene, their care takers must 
be instructed to do it for them. The initial treatment should include treating both the mouth 
and the denture with antifungal creams or ointments, and later the denture can be cleaned 
using soap, bleach or chlorhexidine
20
 (4). Oral hygiene is important for immunocompromised 
patients, but complete recovery is not expected without some other form of treatment.  
 
Ill-fitted dentures 
As mentioned above, ill-fitted dentures can be a contributing cause of denture stomatitis (1). 
In addition to improving oral hygiene, regular relining of the denture is recommended for 
prophylaxis and treatment of denture stomatitis (28). Tissue conditioning is a temporary form 
of relining dentures, which provides the denture with a soft, cushioning base, allowing the 
mucosa to heal and normalize in shape (28). After about two weeks, sometimes in 
combination with topical antifungal therapy, the soft material can be replaced by a permanent 
relining, often preformed by the dental technician. Alternatively, an autopolymerising, hard 
reline material can be used (28). Relining dentures to improve the vertical dimension, after 
resorption of the alveolar bone, will also be helpful for treating angular cheilitis (13).  
 
Hyposalivation 
Treating hyposalivation is a part of treating fungal infection, and strategies include frequent 
hydration and saliva substitutes (4). Pilocarpine and cevimeline can be prescribed as they 
increase salivary flow (4), but they are not registered for use in Norway. If hyposalivation is 
caused by medication, the prescriber should be consulted in regards to finding an alternative 
(4).   
 
                                                          
20
 Chemical with antibacterial and antifungal properties. Suitable for disinfection of the mouth.  
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Steroid inhalers 
If the use of steroid inhalers is a contributing cause of infection, the patient should rinse the 
mouth after use, or alternatively use a spacer device that causes less of the medication to end 
up in their mouth (4).  
 
Immunosuppression 
The most difficult patient to treat is the immunosuppressed patient. This could be a patient 
undergoing treatment for an autoimmune disease, receiving cancer treatment, suffering from 
HIV infection, living with a genetic disorder or any number of rare conditions that affect the 
immune system. Immunosuppression during cancer treatment is usually temporary, the 
greatest challenge being the resulting hyposalivation (4, 11). Patients with recurring oral 
candidiasis due to HIV infection should always be treated in collaboration with their 
physician. The prophylactic use of antifungal medicine in these patients is sometimes 
necessary, but can be problematic as it can lead to resistant organisms (4, 29).  
 
Topical antifungal therapy  
After the predisposing factors have been identified, and as they are being managed, the 
infection can be treated with antifungal medicine. The approved first line of treatment in 
simple cases of oral candidiasis is topical agents (4, 13, 14). They have few adverse effects in 
comparison to systemic treatment, and can be used in combination with systemic treatment as 
it lessens the dose and duration (13). The topical agents exist as oral suspensions, pastilles, 
creams, and tablets. In order for the medicine to have optimal effect, the patient should not 
rinse their mouth, eat or drink for at least one hour after use (4). There is large variety of these 
medications world-wide. In Norway, nystatin (Mycostatin), clotrimazole (Canesten, 
Klotrimazol), and miconazole (Daktar) are among the available choices.   
 
Nystatin  
Nystatin is widely used and comes in many different formulations, usually liquid suspensions, 
creams and pastilles, and its efficacy is largely dependant on contact with the oral mucosa or 
fungal cells (4, 22). It is poorly absorbed from the gastrointestinal tract, so it can be 
swallowed after oral use, but sometimes with the adverse effect of nausea, leading to vomiting 
and diarrhoea (10). It has a bitter taste, despite a high sugar content, and patient compliance 
can be difficult (7, 22). Nystatin is a polyene antifungal agent, and it works by binding to 
17 
 
ergosterol
21
 in fungal cell membranes (10). The amphipathic molecule inserts itself into the 
cell membrane where it aggregates and forms pores, causing efflux of cations, and resulting in 
cell death (30).   
 
Clotrimazole 
Clotrimazole is an alternative to nystatin that is especially useful in angular cheilitis, due to its 
effect on both Candida and Staphylococci (7, 22). In Norway it is available as a cream. It 
rarely causes adverse effects when applied topically, but nausea, vomiting and local skin 
irritation may occur (7). Clotrimazole belongs to the imidazoles, a subgroup of azole 
antifungals (7). The molecule binds to the fungal cell wall, causing alterations to the 
permeability that result in cell death (10).  
 
Miconazole 
Miconazole is a broad spectrum antifungal agent that can be used both topically and 
systemically, though its systemic use has been stopped as there are less toxic alternatives (7). 
It is an azole drug, and it has antifungal and antibacterial properties. It has several 
mechanisms, one of which is inhibition of ergosterol synthesis (10). Miconazole should not be 
used in combination with the anticoagulant warfarin, as it can increase anticoagulant effect to 
a potentially dangerous level (4, 7). 
 
Systemic antifungal therapy 
Systemic antifungal therapy is preferred in severely immunocompromised patients, and the 
treatment is usually led by a physician. Fluconazole is the preferred agent (4). Fluconazole is 
absorbed well in the gastrointestinal tract and can be taken orally with good effect (13). 
Because of its long half-life, fluconazole tablets need only be administered once a day (4). It 
has some side effects, like nausea, headache, gastrointestinal discomfort and abdominal 
discomfort, but these are usually mild (7). Like miconazole, fluconazole disrupts the 
ergosterol synthesis in the fungal cell, causing the leakage in the cell membrane and cell death 
(13). Fluconazole is usually effective against C. albicans, but C. glabrata is frequently 
resistant.   
 
                                                          
21
 Molecule found in fungal cell membranes, with the same function as cholesterol in animal cells, namely 
maintaining proper membrane permeability and fluidity.  
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Invasive candidiasis – systemic infections 
Like the oral cavity, Candida spp. can infect the skin, respiratory system, genitalia, and the 
rest of the gastrointestinal tract. These are all categorized as superficial infections. Invasive 
candidiasis is a term that excludes the superficial infections, and includes more severe 
conditions such as candidemia, endocarditis (affecting the heart), and meningitis (affecting the 
brain) (12). Patients in intensive care with complex medical and surgical disorders are 
especially at risk, with high prevalence, morbidity, and mortality (31, 32). These are, for 
example, patients with burns, neutropenia, HIV infection and pancreatitis (33).  While there 
are many different antifungals available for treatment of invasive candidiasis, there is no early 
reliable diagnostic test. This is why targeted treatment might be difficult, and is increasingly 
accompanied by early treatment strategies, such as prophylactic antifungal treatment (29). 
However, the rise of non-albicans Candida involved in candidiasis might be attributed to 
wide use of azoles, to which C. glabrata, amongst others, have shown resistance (29). 
Selection of azole-resistant Candida spp. should always be a concern when prescribing 
antifungals.  
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Part 2: Molecular epidemiology of Candida glabrata 
 
Molecular epidemiology (ME) 
Epidemiology is the study of health and disease in a population, as well as the cause, patterns 
and effects of disease and death. Included in the term are all forms of health related topics and 
diseases. Epidemiological studies can determine the risk factors of various diseases, and is 
therefore of high importance to public health issues (34).  
 
“I propose the following definition of ME, which clearly states its double goal: 
(i) definition, identification and tracking of pathogen species, subspecies, strains, 
clones and genes of interest by means of molecular technology and evolutionary 
biology; 
(ii) evaluation of the impact of the genetic diversity of a pathogen on its relevant 
medical properties, such as pathogenicity or drug resistance (downstream studies).”  
– Michel Tibayrenc (35). 
 
ME has the same aim as other branches of epidemiology, but the methods in use are on a 
molecular scale, looking at proteins, DNA, RNA, and other cell structures that can determine 
the cause and development of disease.  Why is molecular epidemiology in particular 
important? When dealing with microorganisms, there are few phenotypic traits to look at, and 
an individual organism’s pathogenicity can rarely be determined by appearance only. With 
methods in ME, we can now discriminate between strains based on their genetic variations, 
which will enable us to separate phenotypically identical strains.  
Multilocus sequence typing 
Multilocus sequence typing (MLST) was developed by Maiden et al. (36) for the pathogen 
Neisserria meningitidis
22
 in 1998, but it has since then been applied to many different bacteria 
and fungi. MLST is a tool in ME used to genetically discriminate between strains on a sub-
species level
23
. Previously used methods (1980´s and 1990´s) with the same purpose include 
pulse-field gel electrophoresis (PFGE) and multilocus enzyme electrophoresis (MLEE), 
which used electrophoretic gels to separate different strains.  
 
                                                          
22
 Bacteria that can cause meningitis.  
23
 Separating the individual strains within a given species.  
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MLEE analyses the core metabolic, or ‘housekeeping’, genes, by looking at the differing 
electrophoretic mobilities of the gene products
24
 (37). These genes are suitable for such 
studies because they typically evolve at a slow rate. They are essential for the cells survival, 
and thus, frequent mutations in these genes can cause the entire population to die. Genes 
associated with virulence typically evolve at an accelerated rate, as these are highly 
influenced by the cells environment (37).  
 
MLST, like MLEE, uses housekeeping genes to distinguish between strains. While MLEE 
examines the cell’s enzymes in order to study the genome, MLST looks at the DNA sequence 
of the corresponding genes directly. In MLST, 4-8 gene fragments are used, variations within 
the genes are assigned alleles, and variation in these alleles give each strain an allelic profile, 
or sequence type (ST) (37). The housekeeping genes utilized must not overlap, and instead be 
spread around the chromosome. It is important to have an ideal amount of diversity within the 
gene fragments, but whether it is a definite housekeeping gene or not, is sometimes a difficult 
distinction (37).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
 
The DNA sequences themselves, their alleles, and sequence types can all be stored in an 
MLST database. The disadvantage of MLEE was that the results were difficult to compare 
between laboratories. MLST, however, does not face that problem, as the results are indexed 
directly by the nucleotide sequence, readily available for download from the Internet. While 
MLST is great at discovering single base mutation, it is insensitive to homologous 
recombination
25
, in which large sections of DNA is rearranged (37). 
  
In 2002, MLST was found to be very useful in subspecies characterization of C. albicans (38). 
The challenge of using MLST with C. albicans is that it is a diploid organism
26
, and the 
presence of heterozygosity
27
 can complicate the process. Despite this, many satisfactory 
results have been achieved, and an online global database was established.  
 
                                                          
24
 The gene products are placed on a gel, and a current is run through it. This causes them separate by size and/or 
charge. The result can be visualized with colouring agents and a UV light.  
25
 Large sections of DNA are moved, replaced, or switched, which happens during DNA repair, meiosis and 
horizontal gene transfer.  
26
 Cells that have two homologous copies of each chromosome. Haploid is the counterpart, only having one set 
of chromosomes.  
27
 The two chromosome copies in a diploid organism have different alleles. 
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MLST and C. glabrata  
As described in Part 1, C. glabrata, formerly classified as Toruplopsis glabrata (39), has 
emerged as an important opportunistic pathogen, and is increasingly implicated in human 
infections. C. glabrata was thought to be commensal and a part of the normal flora in humans, 
but has been found to be prevalent in systemic infections and is associated with high mortality 
(20). C. glabrata is the second or third most commonly isolated Candida spp. from reported 
cases of candidiasis, depending on the site of infection (20). It is the most prevalent non-
albicans Candida in humans (40).  
 
In 2003, Dodgson et. al. developed an MLST scheme for C. glabrata (41). They found 6 loci 
(FKS, LEU2, NMT1, TRP1, UGP1 and URA3, see table 2) that were variable enough to 
produce 30 STs among 109 strains. They tested 9 additional loci, but it did not increase 
discrimination. The amount of variable sites was similar to what had been previously found in 
C. albicans. The system for C. albicans seems to be more discriminating than the one for C. 
glabrata, which can be owed the fact that C. albicans is diploid, while C. glabrata is haploid 
(41).  
 
In addition to creating the MLST scheme for C. glabrata, they identified 5 major clades 
among the isolates, 3 of which exhibited significant geographical bias (41). They also looked 
for an association between fluconazole resistance and ST, but found no correlation. In a later 
study (42), they used MLST and found some occurrences of recombination in C. glabrata, 
which has a predominantly clonal population structure
28
. This was later supported by Lott et. 
al. (43), who used MLST to find evidence for both recombination and clonality in the species.  
 
                                                          
28
 No horizontal gene transfer, see below. 
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Locus Gene product GeneBank 
accession no. 
Primer Primer sequence (5'-3') Annealing 
temp. (°C) 
FKS 1,3-Beta-glucan 
synthase 
AF229171  
 
FKS F1
a
 
FKS R1
b
  
 
GTCAAATGCCACAACAACAACCT 
AGCACTTCAGCAGCGTCTTCAG  
 
55.0 
LEU2 3-Isopropylmalate 
dehydrogenase 
 
U90626  LEU2F1 
LEU2R1  
TTTCTTGTATCCTCCCATTGTTCA 
ATAGGTAAAGGTGGGTTGTGTTGC  
54.0 
NMT1 Myristoyl-CoA, protein 
N-myristoyltransferase
c 
AF073886  NMT1F1 
NMT1R1  
GCCGGTGTGGTGTTGCCTGCTC 
CGTTACTGCGGTGCTCGGTGTCG  
59.0 
TRP1 Phosphoribosyl-
anthranilate isomerase 
 
U31471  TRP1F1 
TRP1R1  
AATTGTTCCAGCGTTTTTGT 
GACCAGTCCAGCTCTTTCAC  
50.0 
UGP1 UTP-glucose-1-
phosphate 
uridylyltransferase 
 
AB037186  UGP1F1 
UGP1R1  
TTTCAACACCGACAAGGACACAGA 
TCGGACTTCACTAGCAGCAAATCA  
57.0 
URA1 Orotidine-5’-phosphate 
decarboxylase 
L13661 URA3F1 
URA3R1 
AGCGAATTGTTGAAGTTGGTTGA 
AATTCGGTTGTAAGATGATGTTGC 
53.0 
Table 2: Oligonucleotide primers for amplification and sequencing of loci used in MLST scheme. Table 2 
from Dogdson et. al.(41) 
a
Forward primer 
b
Reverse primer 
c
CoA, coenzyme A. 
 
Material and study design 
As mentioned in the preface, my thesis is part of a much bigger project, using more than 250 
strains of C. glabrata. My part consists of 15 strains, and was chosen randomly after the 
majority of the 250 strains had their DNA extracted, amplified and sequenced. All the 
samples were gathered from human hosts, but sites and indications vary (see table 3). The 
strains are assigned numbers according to their place in the original project.   
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Strain Source  Strain Source 
122 Venous catheter needle  121 Intestinal anastomosis  
133 Blood  143 Intestinal aspirate 
134 Tracheal secretion  144 Oesophagus 
139 Blood  155 Oral 
145 Expectorate   
 
146 Blood   
 
148 Blood   
 
152 Blood   
 
156 Pharyngeal secretion   
 
159 Pleura   
 
161 Thorax   
 
Table 3: The 15 strains and their source. On the right are strains gathered from systemic infections, blood and 
respiratory organs. On the left are strains gathered from the oral cavity, as well as other locations in the 
gastrointestinal tract. 
 
Methods: PCR, DNA sequencing and MLST 
Polymerase chain reaction (PCR) 
PCR is a highly efficient method of amplifying specific DNA segments. In a short amount of 
time, millions of copies can be synthesized. The process is done in vitro, excluding bacteria 
from the method. The desired DNA segment is denatured and annealed
29
 with tailored primers 
(see table 2), and the reaction cycles through different temperatures, allowing the specific 
reactions to occur. Every round each strand of DNA doubles, causing exponential 
accumulation of the defined segment. PCR has simplified how molecular studies are done, 
and many additional uses have been discovered since its introduction in 1985 (44).  
 
In this study, we used the primers defined by Dodgson et al. (41) to amplify the specific loci 
we needed for the MLST. If the sequence is known, primers can be synthesized exactly to fit 
the segments we are looking for. Commercial laboratories can provide researchers with 
custom primers, and usually they can be ordered and received in a few days.  
 
                                                          
29
 Breaking the bonds between the two strands of the DNA molecule, and then recreating the bonds with a primer.  
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Once the DNA was extracted from the different strains of C. glabrata, we could begin 
amplifying the six different segments. Some care had to be taken in establishing the best 
protocols
30
 for the PCR, and we found that the different primers needed different conditions 
for optimal reactions. The quality of the amplified sequences was examined using gel 
electrophoresis, which was also a useful tool in finding the best protocols.  
 
DNA sequencing 
There are many different methods of sequencing DNA, but the purpose is to determine the 
order of nucleotides within a selected DNA strand. This process has countless uses, and in this 
study our aim was to determine the specific sequence at each loci of each C. glabrata strain, 
so we could use that information for the MLST. 
 
Using Sequencher
31
, DNA sequence analysis software, the forward and reverse sequence for 
each strain and each locus were assembled and corrected.  
 
 
Example of a Sequencher electropherogram
32
 
 
MLST 
The finished sequences were then typed, using the MLST database to match the sequence to 
its allele. The alleles from each locus were then matched up to the established STs.  
 
                                                          
30
 The temperature of each step in the process, as well as the time it remains at each temperature.  
31
 Sequencher by Gene Codes Cooperation. See http://www.genecodes.com/ for more information. 
32
 Visual representation of a DNA sequence in sequencing software after electrophoresis automatic sequencing. 
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Results and discussion 
 
Strain FKS LEU2 NMT1 TRP1 UGP1 URA3  ST 
121 7 7 11 10 New allele - A 9  New ST - A 
122 3 9 26 4 New allele - C 4  New ST - C 
133 5 7 8 7 3 6  3 
134 3 9 26 4 New allele - C 4  New ST - C 
139 5 7 8 7 3 6  3 
143 3 9 26 4 New allele - C 4  New ST - C 
144 3 9 26 4 New allele - C 4  New ST - C 
145 5 7 8 7 3 6  3 
146 3 4 4 3 3 4  7 
148 5 7 8 7 3 6  3 
152 3 9 26 4 New allele - B 4  New ST - B 
155 1 2 2 1 2 1  8 
156 1 2 2 1 2 1  8 
159 3 9 26 4 New allele - C 4  New ST - C 
161 12 4 16 5 1 8  25 
Table 4: The strains with their alleles and STs. New alleles were assigned a letter (A, B and C), as were the 
resulting new STs. The ST can only be determined once the alleles for each locus are found.  
 
In the larger project, the MLST results can be used to analyse the genetic diversity of C. 
glabrata, but the 15 strains I worked with are not sufficient to draw any conclusions. I will, 
however, discuss some of the possible results from these types of studies in molecular 
epidemiology.  
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Locus Fragment 
length (bp) 
No. of 
alleles 
No. of alleles 
(previously 
registered)* 
No. of 
polymorphic 
sites 
% variable 
nucleotide sites 
FKS 589 5 25 8 0,01 
LEU2 512 4 18 5 0,01 
NMT1 607 6 34 15 0,03 
TRP1 419 6 23 9 0,02 
UGP1 616 6 13 9 0,02 
URA3 602 5 20 8 0,01 
Table 5: The characteristics of each locus. The fragment length shows the amount of basepairs (bp) in each 
locus. No. of alleles is the amount of different alleles found in this project, and this is compared to the amount of 
alleles in the MLST database. No. of polymorphic sites shows the amount of polymorphic sites within each locus, 
and this is used to calculate the percentage of variable nucleotide sites
33
.  
*from http://cglabrata.mlst.net/, cited 22.3.14 
 
New alleles and sequence types 
In studies with a higher number of strains (>1000), one can expect to find new variations in 
the genes that have not previously been registered in the MLST database. Table 5 shows the 
amount of alleles for each locus previously registered. 
 
Out of the 15 strains, there were 3 new alleles not yet registered, and they were all in the 
UGP1 gene (see table 4). They were temporarily named A, B and C. A only differed from a 
previous allele (UGP1-5 allele) in one polymorphic site. B also differed from a previous allele 
(UGP1-3 allele) in one site. C’s closest match was also UGP1-3 allele, but the one differing 
site was not the same as B.  
 
C. glabrata has 70 STs previously registered. In these 15 strains, 7 STs were found, 3 were 
new (see table 4). The new alleles in UGP1 made up 3 new STs, also named A, B and C. A 
was closest to ST 16. B and C were close matches with each other, but not to any previous ST.   
 
The percentage of variable nucleotide sites is quite low for all the loci (0,01-0,03 %, see table 
5). Dodgson et al. (41) found  1,3-3,5 % variable nucleotide sites in their study with 109 
isolates of C. glabrata.  
                                                          
33
 The location of a base that varies from strain to strain.  
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Example of a polymorphic site: In the FKS locus, base 238 of 589 is a polymorphic site. In 
strain 133 this is a C (blue) and in strain 155 this is a T (red).  
 
Geographical distribution 
When large amounts of strains are gathered from different continents, it is possible to see if 
the species’ genetic diversity is linked to their physical location in the world. MLST is 
particularly useful for this purpose, as data from all over the world is comparable. Dodgson et 
al. found that C. glabrata has distinct genetic clades
34
 that are more common in different 
geographical regions (41).  
 
Population structure 
A population of microbes can have different sets of genetic population structures. It was 
previously believed that bacteria adhere to a clonal population structure (45). This means that 
one individual is the source of all genetic material in each descendant, and that any variation 
is the result of mutations within each individual. See Fig.1 A below. Alternatively, a panmitic 
population structure allows horizontal gene transfer between individuals, see Fig. 1 B. This 
represents a complete meshwork of exchange of genetic information, and the ancestors will be 
much more difficult to track than in clonal populations (45). The third population structure is 
the epidemic where genetic exchange is swapped freely in an underlying pandemic situation 
with the rise of branches of purely clonal complexes on top, which can be responsible for 
epidemic disease outbreaks.(see Fig. 1 C) (45).  
                                                          
34
 A group of individual organisms within a species, the ancestor and all its descendants.  
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Models of different population structures 
Fig. 1 from Smith et al. 1993 (45) 
 
Calculations can be done to determine the likely population structure of a species. The index 
of association (IA) is one parameter, developed by Brown et al. (46) in 1980 for the study of 
wheat. With a larger number of strains, it is possible to determine if C. glabrata has a clonal 
population structure. Dodgson et al. (42) and Lott et all. (42) both concluded that, although C. 
glabrata has a mainly clonal population structure, recombination most likely also plays a role.  
 
Phylogenetics   
A phylogenetic tree, or dendrogram, is a diagram showing the relationship between different 
species, or different strains within a species, based on their genetic determinants. In my 
project, the STs decide how the strains are related to each other based on concatenated 
sequences of 6 genes (MLST) of the C. glabrata strains investigated.  
29 
 
 
Phylogenetic tree shows the relationship between different strains of C. glabrata  
 
 
In the coming years, more information will be available as methods in molecular 
epidemiology are under constant development. This will provide us with further 
understanding and clarity when studying the world of microorganisms.  
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